2025-01-06 - Cancer Synoptic Reporting Project Group Meeting

Updates:

1. CAP publication planning
   1. Data conversion work (end of 1st qtr for distribution)
   2. Manuscript update
2. ICCR update - No updates since last meeting.  Adminstriviation pending

Oslo Meeting - Apirl 6 - 9

Paraganglioma vs. Pheochromocytoma and related findings/disorders

716857003 |Hereditary pheochromocytoma and paraganglioma (disorder)|

Can we call this Hereditary paraganglioma?  Pheochromocytoma is subsumed by paraganglioma.

Necrotic nephroblastoma

Clinical findings resolution - Still in process

1. Need to determine the scope/extent of use of current content used in each organization/community of practice.
   
   1. Content at issue
   2. Recommended plan
   3. Rationale to do change
   4. ID deficiency of existing content
   5. Define implausibility of editing existing
   6. How are you using existing content?
   7. How are you overcoming deficiencies with current content?
      
      
2. Impact of change on your organization?
   
   
3. What is the process for transition?  Needs to be articulated in the briefing note/consultative note
   
   
4. What to do with legacy content...how to handle it?  How convert old content to new representation needs to be articulated...implementation question.
   
   
5. How does this group engage with adoption/transition/implementation?
   
   
6. Make sure that link to implementation guide included.
   
   
7. Discuss approach vs. pre-coordination

1. CSRWG will wrap up by April Business Mtg - 2025
2. Ongoing working groups
   1. Histology Quality
   2. WSI? - Laszlo Igali favors this
   3. IHC?
   4. Medical synoptics
   5. Artificial Intelligence, pathology and synoptic reporting.  Paul Seegers favors this
   6. Implementation focus?  
      1. Implementation
      2. links to WSI
      3. links to AI
      4. Metadata!